EarlySign Signs Agreement with Roche on AI Solution for Early Lung Cancer Detection
Medial EarlySign signed a new partnership with Roche to create innovative, evidence-based solutions for early detection of lung cancer.
Read More
Search Results for: lung cancer
Artemis DNA Cuts Texas Operations, Shifts Focus to Oncology Portfolio in California
Global diagnostic laboratory company Artemis DNA closed its Houston, Texas facility to optimize the company’s strategy in California.
Read More
International Collaborators Focus on Biomarkers for Early Cancer Detection
The USA-Japan Workshop on Biomarkers for Cancer Early Detection presented research on the early detection and prevention of cancer.
Read More
Companion Diagnostic for ROS1-Positive Lung Cancer Approved
FoundationOne CDx has been approved by the FDA to be used as a companion diagnostic for the two indications of Rozlytrek (entrectinib).
Read More
Blood Biomarker More Accurately Predicts Lung Cancer Immunotherapy Response than Tumor Biopsy
A simple blood test could be an ideal predictor of whether cancer immunotherapy will be successful for a lung cancer patient.
Read More